Impact of Serum GDF-15 and IL-6 on Immunotherapy Response in Cancer: A Prospective Study
Our findings indicate that GDF-15 could serve as a prognostic biomarker for immunotherapy response and may also be a target for cachexia management. Further studies should explore its potential to guide clinical decision making in oncology.
Authors
- Nuriye Özdemir (ORCID: https://orcid.org/0000-0002-9235-9592)
- Kadriye Bır Yucel (ORCID: https://orcid.org/0000-0002-4745-1605)
- Seval Türkmen (ORCID: https://orcid.org/0000-0002-4016-4777)
- Orhun Akdoğan (ORCID: https://orcid.org/0000-0003-0212-1191)
- Cengiz Karakaya (ORCID: https://orcid.org/0000-0002-0399-9150)
- Ahmet Özet (ORCID: https://orcid.org/0000-0001-8731-9636)
- Osman Sütçüoğlu (ORCID: https://orcid.org/0000-0003-3835-2741)
- Ozan Yazıcı (ORCID: https://orcid.org/0000-0003-2844-0959)
- Burak Tüfekçi (ORCID: https://orcid.org/0000-0002-7029-0109)
- Galip Can Uyar (ORCID: https://orcid.org/0000-0002-0698-777X)
- Fatih Gürler
Institutions
- Memorial Ankara Hospital (TR)
- Gazi University (TR)
Publication Details
- Journal
- Cancers
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3390/cancers16244146
- Citations
- 6
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.82